INTRODUCTION
The occurrence of cryoproteins in the sera of patients with diverse disease states is widely recognized, and has been the subject of numerous detailed studies (1) (2) (3) (4) and reviews (5, 6) . Analysis of serum cryoproteins generally has revealed a single protein moiety possessing the property of cold insolubility; or a mixture of two or more immunoglobulins, one possessing rheumatoid factor like A preliminary report on this work appeared in abstract form (Arthritis Rheum. 1967 . 10: 296).
Received for publication 25 May 1970 and in revised form 8 October 1970. activity. However, the occurrence of cryoproteins in synovial fluid has not been reported previously.
During studies on a complement-fixing activity in rheumatoid synovial fluid (7) , it was noted that the greater portion of this activity as detected in whole synovial fluid was cold precipitable (8) . These complement-fixing synovial fluid cryoproteins appear in some ways similar to the mixed cryoproteins occurring in the serum of patients with SLE, most recently studied by Christian, Hatfield, and Chase (9) and Hanauer and Christian (10) in that they are composed of multiple immunoglobulin types, bound complement components, and are associated with depressed supernatant fluid complement levels.
Cryoproteoins have been found in nonrheumatoid synovial fluids also, but with rare exception have been devoid of complement-fixing activity, and unassociated with depressed synovial fluid complement levels. In this paper, studies of the composition, sedimentation characteristics, and complement-fixing activity of synovial fluid cryoproteins are presented.
and shell frozen in a mixture of dry ice and 2-methoxyethanol, and stored at -70'C for studies at a later date. This procedure failed to generate additional complementfixing activity, and usually fluids were free of precipitate on rapid thawing at 370C.
Whole complement titration.1 Complement determinations were performed on synovial fluid using a 7.5 ml reaction volume and under the conditions described in (12) . Veronalbuffered saline, pH 7.4, was prepared as described. Gelatin, CaCl2, and MgSO4 were added to final concentrations of 0.1%,o, 0.15 mmole/liter, and 1 mmole/liter, respectively (Gel VB). The titer expressed in terms of CH50 units/ml is defined as the reciprocal of that dilution of synovial fluid, 1 ml of which will produce 50% hemolysis of the standardized red cell suspension.
Titration of C1. The first component of human complement (Cl) was titrated using a modification (13) of the technique of Becker (14) , employing guinea pig complement components.
Complement-fixing activity. Assays for complement-fixing activity were performed on whole synovial fluid, unwashed cryoprecipitate, and residual supernate as follows. 1 ml of synovial fluid was placed in a i X 2 inch centrifuge tube, and kept at 0C for 18 hr. The cryoprecipitate which formed was then resuspended, and a 0.1 ml aliquot removed for assay of whole fluid complement-fixing activity, and placed in a tube containing 0.4 ml of Gel VB. The 0.9 ml residual was then centrifuged at 00-40C, 15 ,000 g, for 15 min. The supernatant fluid was then removed, the tube wall wiped free of residual supernate, and the precipitate resuspended without washing in 0.9 ml of Gel VB. Precipitate resuspension was aided by a small motor with an eccentric rubber tip attached to its shaft. Aliquots of supernate and precipitate, 0.1 ml, were added to separate tubes containing 0.4 ml of Gel VB. 2 ml of an appropriate dilution of human complement containing a total of 7-8 CH5o units were added to all three tubes, and appropriate control tubes. The tubes were incubated for 1 hr at 37°C, following which 10 ml of Gel VB was added, and the residual complement titrated in the 7.5 ml reaction volume described above. Residual complement was calculated, and the results subtracted from the complement control, yielding the amount fixed by the test material. Results are expressed in terms of per cent complement fixed by 0.1 ml of test material, unless otherwise indicated.
Washing of synovial fluid cryoprecipitates. In initial assays not presented, washing of synovial fluid cryoprecipitates with isotonic buffer pH 7.4 resulted in loss of large and variable amounts of complement-fixing activity up to 63%o of that originally present in the cryoprecipitate. In some fluids with small amounts of complement-fixing activity all of the activity was lost with washing. It was found that this loss could be decreased by washing in a low ionic strength buffer. Accordingly, a washing procedure consisting of two washes of cold (00-40C) 0.02 M, pH 7.4 Veronal buffer followed by final resuspension in 0.02 M, pH 7.4 Veronal-buffered saline, was employed. The wash volume was one-half the initial sample volume; and the tube wall was wiped dry between washes. At final resuspension, the cryoprecipitate was concentrated four times with respect to initial sample volume. This allowed the increased sensitivity necessary for some of the chemical determinations. Singer and Plotz (22) . A micromethod employing one-tenth the volume and 5 X 50 mm glass tubes was used for the density gradient studies. Density gradient studies. All sucrose preparations examined, including a purified density gradient grade, contained nondialyzable dextran contaminants, confirming previous observations (23) . These contaminants reacted with all normal human and guinea pig sera tested, activating the complement sequence and invalidating complement-fixation studies. -After testing several sugars, sorbitol was found to be most satisfactory as a sucrose subtitute with respect to noninterference with the complement sequence, although it must be removed by dialysis before protein and DNA determinations. Synovial fluid density gradient analysis was performed using a 10-80% (wt/vol) gradient, in isotonic Veronal-buffered saline pH 7.4 Identification of complement components by hemtolytic assay. Following washing, the first component of complement (Cl) was detected in five of six nonrheumatoid and all of twelve rheumatoid cryoprecipitates tested. In an attempt to relate the cryoprecipitate-associated complement-fixing activity to the consumption of C1, the per cent of total synovial fluid C1 which was cryoprecipitate bound is plotted (ordinate) as a function of whole complement-fixing activity by that cryoprecipitate (abscissa) (Fig. 3) . In general, the greater the complement-fixing activity, the greater was the per cent of total synovial fluid C1 which was cryoprotein bound. In Fig. 4 . In the nonrheumatoid cryoprecipitates, there was absolute agreemept between chemical and immunochemical determinations, DNA being detected in 6/10 cryoprecipitates (Table II) . In spite of a low ionic strength wash, considerable amounts of DNA were lost with washing, up to 65% of that initially present. Accordingly cryoprecipitate DNA values represent only a portion of that initially present. (Tables I and II) (16) . However, the values of 13, 10, and 17 /Ag/ml for the three fluids are in excess of the serum values of 1-3 /Lg/ml which those authors reported. In view of the range of variation, and since some synovial fluid supernates possessing as little as 8 or 9 og/ml diphenylamine-reactive material gave positive precipitin reactions with anti-DNA, supernatant values have been left uncorrected.
Rheumatoid factor. Rheumatoid factor was present in the serum of 12/17 patients with synovial fluid cryoproteins, and was detectable in 17/29 washed rheumatoid cryoproteins. Nonrheumatoid patients lacked rheumatoid factor in their serum and were devoid of rheumatoid factor in their synovial fluid cryoprecipitates.
Density gradient studies. Density gradient ultracentrifugation of a rheumatoid and inflammatory nonrheumatoid (pseudogout) synovial fluid are shown in Fig. 5 . In this assay, rheumatoid factor was determined qualitatively by precipitation of heat-aggregated gamma globulin in agarose gel, and 0.2 ml fractions were analyzed
The Occurrence of Cryoproteins in Synovial Fluid A difference in terms of complement-fixing activity is observed if one compares whole fluid complement-fixing activity with the same fluid subjected to density gradient analysis (Fig. 6) . Examination of noncentrifuged synovial fluid, and extrapolating to a 0.5 ml sample, revealed that a total of 7.3 CHw units were fixed by the sample before cryoprecipitate removal, and 1.4 CH5o units after cryoprecipitate removal, reflecting removal of 81% of the complement-fixing activity with the cryoprecipitate. Following density gradient centrifugation of the cryoprecipitate-containing fluid, the sum of the amount of complement fixed by all nine fractions was 9.5 CHO. units, an increase of 2.2 U over the noncentrifuged sample. In contrast, in the fluid free of cryoprecipitate, the sum of the amount of complement fixed by all nine fractions was 6.7 CH.o units, an increase of 5.3 CHo units over the noncentrifuged sample. This increase in complement-fixing activity following cryoprecipitate removal and ultracentrifugation suggests that the reactants in the complement-fixing process are in a dynamic rather than static state and that in native whole synovial fluid mediately after aspiration of rheumatoid synovial (7), cryoprecipitation per se must be considered a secondary phenomenon, unnecessary for complement fixation and reflecting the formation of larger, cold-insoluble aggregates from those already present in synovial fluid. The kinetic assay of cryoprecipitation ( Fig. 1) further demonstrates this point. Density gradient studies (Fig.  6) confirm the presence of a heavy sedimenting fraction in rheumatoid synovial fluid which contains the complement-fixing activity. It has been possible to utilize cryoprecipitation to separate the complement-fixing complex from the masking effect of complement components in whole synovial fluid, allowing the detection of small amounts of activity undetectable in whole synovial fluid. This was noted in one nonrheumatoid and five rheumatoid synovial fluids in the present study. Subsequently, using larger amounts of cryoprotein, it has been possible to demonstrate complement-fixing activity in cryoproteins from 90% of rheumatoid synovial fluids.
As demonstrated in Fig. 2 , the greater portion of the complement-fixing activity detected in whole fluid is cold precipitable. However, the density gradient studies (Fig. 6 ) indicate that significant additional complementfixing activity can be detected following synovial fluid fractionation. Although the manifold factors possibly controlling this increase have already been mentioned, the prime reason for its increase would appear to be the continued further aggregation of IgG either by itself, or in combination with specific antigen.9 We have observed similar increases in complement-fixing activity accompanying manipulation of properly collected "anticomplementary" sera from patients with SLE and other disease states. It should be emphasized that care has been taken to exclude both a nonspecific, heavy-sedimenting, heat-labile anticomplementary activity present in normal serum and some synovial fluids which becomes manifest on ultracentrifugation, and the use of sucrose which contains nondialyzable dextran contaminants capable of activating the complement sequence.
Within the limits of methods used to detect immunoglobulins, IgG was the sole immunoglobulin in almost 50% of the rheumatoid cryoproteins. This suggests that a mixed immunoglobulin system is unnecessary for complement fixation and cryoprecipitation.
It is as yet unclear whether the C1 and C4 detected in the rheumatoid cryoproteins were bound to the complement-fixing complex in their soluble form at the time of aspiration, or whether they were fixed during the processing. Christian, Hatfield, and Chase have shown that Clq is required for precipitation of mixed cryoproteins in SLE serum (9) . However, the bound C1 which we have detected using cell intermediates reflects 'Manuscript in preparation. a different portion of the C1 complex, mitigating valid comparison at the present time.
The association of fibrin or its breakdown products with rheumatoid synovial inflammation has been previously noted (26) . A report that treatment of normal plasma with thrombin generates cryofibrinogen is most pertinent (27) (36) , and Clq at alkaline pH (37) , illustrate the propensity of DNA for ionic and apparent nonspecific interaction. Alternately, a portion of the DNA in the cryoprecipitate may be specifically combined with immunoglobulin as an antigen-antibody complex. This would be in agreement with observations of the occurrence of antinuclear factors in rheumatoid synovial fluid (38) , and would support the hypothesis of Zvaifler that altered nuclear material could represent a potential antigen in rheumatoid synovial inflammation (39) . It should again be emphasized that considerable amounts of both DNA and complement-fixing activity are lost with washing, and that the chemical and immunochemical determinations presented on the washed cryoprecipitates represent an exceedingly rough approximation of the materials initially present. In an attempt to clarify the role of DNA in these complexes, studies of inhibition of rheumatoid synovial fluid complement fixation have implicated a site or sites on denatured DNA as an antigenic determinant in these complexes (40) . Subsequently, using a direct approach, it has been possible to dissociate partially the cryoprotein complex in a 15% sodium chloride, sorbitol gradient. Both IgG, and IgG-and IgM-containing fractions which contain variable amounts of DNA, have demonstrated the capacity for increased complement fixation upon addition of denatured calf thymus DNA. No significant complement fixation has been obtained to date with native DNA.9 The role of rheumatoid factor in modifying complement fixation by this complex, the detection of antibody to denatured DNA in nonrheumatoid cryoprecipitates, and the role of other potential antigens must be clarified by additional studies.
The relationship between the complement-fixing cryoproteins described in these studies and synovial fluid IgG globulin aggregates described by Hannestad (41) and studied in further detail by Winchester, Agnello, and Kunkel (42) , and soluble antigen-antibody complexes described by Baumal and Broder (43) is not entirely clear at the present time. It would appear that synovial fluid cryoproteins and the associated complement-fixing activity of rheumatoid cryoproteins per se, are distinct from the aforementioned, since these authors stored their fluid at 4°C, and Baumal and Broder removed cryoprecipitable material before assay (44) . Nevertheless, there is a strong indication that we are dealing, at least in part, with the same activity, since a portion of the complement-fixing activity is associated with IgG sedimenting heavier than 19S, and cryoprecipitation effects only partial removal. However, the detection methods differ with regard to specificity, those of Hannestad (41) , and Baumal and Broder (43) detect aggregates or soluble antigen-antibody complexes respectively, composed of IgG only; while our assay system utilizing complement fixation as described detects IgM and certain IgG antigen-antibody complexes or aggregrates, and possibly antigen-antibody-complement intermediates. This, plus the finding of DNA and specific antibody in association with the cryoprecipitable portion of this activity, suggests that any conclusive statement with regard to identity of these synovial fluid factors be deferred pending additional studies.
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